LumiThera, Inc. | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Video & Media
Email & Communication
Keywords & Focus Areas
LumiThera, Inc.
Overview
LumiThera, Inc. is a U.S.-based medical device company founded in 2013, led by President & CEO Clark E. Tedford, Ph.D. The company specializes in non-invasive treatments for degenerative eye diseases, particularly dry age-related macular degeneration (AMD), a major cause of blindness globally.
LumiThera utilizes photobiomodulation (PBM) technology, which employs specific wavelengths of light to stimulate retinal cells, enhancing energy production and blood flow to improve visual function. Its flagship product, the Valeda Light Delivery System (LT-300), is designed to slow the progression of dry AMD and has received FDA authorization. Clinical studies have demonstrated significant improvements in visual acuity for treated patients. LumiThera is committed to research and development, expanding PBM applications to other retinal diseases, and maintains a robust regulatory framework with FDA clearance and CE marking. The company has secured substantial funding to drive product innovation and commercialization.
Basic Information
| Industry | medical devices |
|---|---|
| Founded | 2013 |
| Revenue | 12.5M |
| Headquarters | 19578 10th Avenue NE, Suite 200, Poulsbo, Washington 98370, United States |
| Parent Organization | Alcon |
Contact Details
- Phone: +1 844-342-3333
- Website: lumithera.com
- LinkedIn: linkedin.com/company/lumithera-inc.
Key Focus Areas & Initiatives
- Photobiomodulation
- Age related macular degeneration
- Ophthalmology
- Medical device Innovation
- PBM therapy
- Dry AMD treatment
- Valeda Light Delivery System
- Retinal disease management
- Retinal disease detection
- Visual function improvement
- FDA-approved ophthalmic device
- Retinal health assessment
- Clinical trials
- Vision preservation
- Cellular therapy and enhancement
- Patient safety
- Biotechnology and biophotonics
- Non-thermal light therapy
- Disease modification
- Vision science innovation
- Ocular inflammation control
- Visual acuity enhancement
- Contrast sensitivity improvement
- Retinal disease monitoring
Technologies Used
- AI
- Apache
- Google Analytics
- Google Font API
- Google Maps
- Google Tag Manager
- Google translate API
- Google translate widget
- MailChimp SPF
- Mobile Friendly
- Multilingual
- Outlook
- Remote
- Salesforce
- Tealium
- Typekit
- Vimeo
- Woo Commerce
- WordPress.org
- reCAPTCHA
Community
